VICTORY! WHO quietly halts its risky "Solidarity Trial" of HCQ

[Mark Crispin Miller]

On 17 June 2020, WHO announced that the hydroxychloroquine (HCQ) arm of the Solidarity Trial 

to find an effective COVID-19 treatment was being stopped. 

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments

From Dr. Meryl Nass:

Update June 18:  I sent a tweet to WHO Director General Tedros informing him of these findings 3 days ago.  

I also emailed WHO's Dr. Restrepo, inquiring about the doses used in the Solidarity trial.  I am very pleased to 

report that WHO stopped this deadly trial yesterday, with no fanfare.  WHO claimed the decision was made on 

the basis of the Recovery trial result and a Cochrane review, as well as WHO data.  One wonders if the DSMB 

was bypassed again, as occurred on May 25 when WHO halted its HCQ arm for the first time.

I had pointed out that if trial investigators had not disclosed to subjects the known risks associated with the high 

HCQ doses used, the investigators and WHO would be liable for damages. 

I like to think my investigation has helped save some lives.

https://anthraxvaccine.blogspot.com/2020/06/who-trial-using-potentially-fatal.html